Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Abbott receives WHO prequalification approval for breakthrough HIV point-of-care test

      Abbott receives WHO prequalification approval for breakthrough HIV point-of-care test

      Farhat Nasim5 May 2019 9:45 AM IST
      New Delhi: Abbott recently announced that m-PIMA HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health...
      Cadila Healthcare gets 14 USFDA observations for Moraiya plant

      Cadila Healthcare gets 14 USFDA observations for Moraiya plant

      Farhat Nasim4 May 2019 10:00 AM IST
      The US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
      Generic of Sensipar: US court denies Amgen request for preliminary injunction against Cipla

      Generic of Sensipar: US court denies Amgen request for preliminary injunction against Cipla

      Farhat Nasim4 May 2019 9:45 AM IST
      Cipla's cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg are generic versions of Sensipar, a branded drug marketed by Amgen...
      Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy

      Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement with Otonomy

      Farhat Nasim3 May 2019 10:00 AM IST
      OTIPRIO is a sterile, preservative-free, otic suspension of 6% ciprofloxacin administered as a single-dose by a healthcare professional. Mumbai:...
      AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

      AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

      Farhat Nasim3 May 2019 9:10 AM IST
      New Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat...
      Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

      Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

      Farhat Nasim2 May 2019 4:04 PM IST
      Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
      Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

      Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

      Farhat Nasim2 May 2019 10:00 AM IST
      Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
      RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in Chennai

      RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in Chennai

      Farhat Nasim1 May 2019 12:15 PM IST
      New Delhi: In a major crackdown, the Central Drugs Standard Control Organisation (CDSCO) has confiscated bulk drugs including Erythromycin, Megestrol...
      CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

      CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

      Farhat Nasim30 April 2019 10:15 AM IST
      "SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
      Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

      Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

      Farhat Nasim30 April 2019 10:00 AM IST
      Cipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
      Aurobindo Pharma gets MoEFCC nod for Andhra Pradesh plant expansion

      Aurobindo Pharma gets MoEFCC nod for Andhra Pradesh plant expansion

      Farhat Nasim30 April 2019 9:30 AM IST
      The Rs 250 crore expansion project by Aurobindo Pharma is expected to generate jobs for 600 people directly and 120 indirectly.Hyderabad: The Rs...
      Dr Reddys, Cipla arm recall drugs in US; includes 7.8 lakh vials of Testosterone Cypionate injection

      Dr Reddys, Cipla arm recall drugs in US; includes 7.8 lakh vials of Testosterone Cypionate injection

      Farhat Nasim29 April 2019 9:45 AM IST
      Besides, InvaGen Pharmaceuticals Inc, a subsidiary of Mumbai-based drug maker Cipla, is recalling over 7.8 lakh vials of Testosterone Cypionate...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok